(Q34195803)

31 July 2017

1 reference

title

Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients (English)

1 reference

31 July 2017

B Fulton

1

1 reference

31 July 2017

C M Perry

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

137-158

1 reference

Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00128072-200103020-00006

Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses

21 January 2018

1 reference

12 December 2020

Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist

1 reference

12 December 2020

[Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis]

1 reference

12 December 2020

Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin

1 reference

12 December 2020

Clinical pharmacokinetics of oral cephalosporins

1 reference

12 December 2020

Concentrations of cefpodoxime in serum and bronchial mucosal biopsies

1 reference

12 December 2020

Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media

1 reference

12 December 2020

Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis

1 reference

12 December 2020

Five vs. ten days of antibiotic therapy for acute otitis media in young children

1 reference

12 December 2020

Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil

1 reference

12 December 2020

Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil

1 reference

12 December 2020

Clinical Trials of Cefpodoxime Proxetil Suspension in Paediatrics

1 reference

12 December 2020

Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients

1 reference

12 December 2020

Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

1 reference

12 December 2020

Activity of cefpodoxime, an oral 3rd generation cephalosporin

1 reference

12 December 2020

Antimicrobial therapy of acute otitis media: review of treatment recommendations

1 reference

12 December 2020

[The influence of cefpodoxime proxetil on the intestinal bacterial flora].

1 reference

12 December 2020

Pharmacodynamic activity of five oral cephalosporins against Haemophilus influenzae

1 reference

12 December 2020

Measuring the comparative efficacy of antibacterial agents for acute otitis media: The “Pollyanna phenomenon”

1 reference

12 December 2020

A double-blind taste comparison of pediatric antibiotic suspensions

1 reference

12 December 2020

Clinical study of cefpodoxime proxetil dry syrup for skin and soft tissue infections in the field of pediatrics

1 reference

12 December 2020

Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection

1 reference

12 December 2020

Effect of Timing of Food on Absorption of Cefpodoxime Proxetil

1 reference

12 December 2020

Overall clinical evaluation of cefpodoxime proxetil against infections in pediatric fields

1 reference

12 December 2020

Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Danish-Swedish Study Group

1 reference

12 December 2020

Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years

1 reference

12 December 2020

Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine

1 reference

12 December 2020

Antibacterial activity of cefpodoxime in vitro

1 reference

12 December 2020

[In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae]

1 reference

12 December 2020

In vitro activity of cefpodoxime and ten other cephalosporins against gram-positive cocci, Enterobacteriaceae and Pseudomonas aeruginosa, including beta-lactamase producers

1 reference

12 December 2020

Antibiotic treatment of acute otitis media in children under two years of age: evidence based?

1 reference

12 December 2020

The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances.

1 reference

12 December 2020

Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanate

1 reference

12 December 2020

Microbiological Evaluation of Cefpodoxime Proxetil

1 reference

12 December 2020

Cerebrospinal fluid pharmacokinetics of cefpodoxime proxetil in piglets

1 reference

12 December 2020

Disposition of cefpodoxime proxetil in hemodialysis patients

1 reference

12 December 2020

A pharmacoeconomic comparison of amoxicillin/clavulanate and cefpodoxime proxetil in the treatment of acute otitis media.

1 reference

12 December 2020

Cefpodoxime pharmacokinetics in children: effect of food

1 reference

12 December 2020

Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field

1 reference

12 December 2020

Twice daily cefpodoxime proxetil compared with thrice daily amoxicillin/clavulanic acid for treatment of acute otitis media in children

1 reference

12 December 2020

Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora.

1 reference

12 December 2020

Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers

1 reference

12 December 2020

Serum bactericidal activity against Moraxella catarrhalis and Streptococcus pneumoniae after administration of four oral cephalosporins in healthy volunteers

1 reference

12 December 2020

Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

Effects of nifedipine and diltiazem on pharmacokinetics of cefpodoxime following its oral administration

1 reference

12 December 2020

Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children.

1 reference

12 December 2020

Disposition of cefpodoxime proxetil in healthy volunteers and patients with impaired renal function

1 reference

12 December 2020

Empiric antibiotic selection criteria for respiratory infections in pediatric practice

1 reference

12 December 2020

Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients

1 reference

12 December 2020

Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field

1 reference

12 December 2020

Efficacy of beta-lactam antibiotics: integration of pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis

1 reference

12 December 2020

Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children

1 reference

12 December 2020

Multicenter trial of cefpodoxime proxetil vs. amoxicillin-clavulanate in acute lower respiratory tract infections in childhood. International Study Group.

1 reference

12 December 2020

Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.

1 reference

12 December 2020

Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis

1 reference

12 December 2020

Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo

1 reference

12 December 2020

A Review of the Pharmacokinetics of Cefpodoxime Proxetil

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections.

1 reference

12 December 2020

Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil

1 reference

12 December 2020

[The clinical study of cefpodoxime proxetil dry syrup preparation in the pediatric field]

1 reference

12 December 2020

A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections

1 reference

12 December 2020

In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers

1 reference

12 December 2020

The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins

1 reference

12 December 2020

In vitro activity of cefpodoxime, a new oral cephalosporin

1 reference

12 December 2020

Clinical and pharmacokinetic evaluation of cefpodoxime proxetil in children

1 reference

12 December 2020

Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin

1 reference

12 December 2020

The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil.

1 reference

12 December 2020

Pharmacokinetic, bacteriological and clinical evaluation of cefpodoxime proxetil in pediatrics

1 reference

12 December 2020

Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.

1 reference

12 December 2020

Cefpodoxime proxetil concentrations in head and neck tissues

1 reference

12 December 2020

In vitro activity of cefpodoxime in comparison with other oral beta-lactam antibiotics.

1 reference

12 December 2020

The bioavailability of cefpodoxime proxetil tablets relative to an oral solution.

1 reference

12 December 2020

Management of acute otitis media in the 1990s: the decade of resistant pneumococcus

1 reference

12 December 2020

Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem

1 reference

12 December 2020

Cefpodoxime Proxetil in the Treatment of Skin and Soft Tissue Infections

1 reference

12 December 2020

Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children

1 reference

12 December 2020

Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections

1 reference

12 December 2020

Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil

1 reference

12 December 2020

1 reference

12 December 2020

Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media

1 reference

12 December 2020

Human skin disposition of cefpodoxime after oral administration of its proxetil ester

1 reference

12 December 2020

Duration of therapy for acute otitis media

1 reference

12 December 2020

Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials

1 reference

12 December 2020

Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil.

1 reference

12 December 2020

Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients

1 reference

12 December 2020

10.2165/00128072-200103020-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1044859212

0 references

1 reference